| Financial Year |
March 31 2023 |
| Monetary Funds |
658,452,394.74 |
| Held-for-trading Financial Assets |
180,300,000.00 |
| Notes Receivable |
6,721,767.77 |
| Accounts Receivable |
101,567,543.51 |
| Advances to Suppliers |
6,637,445.82 |
| Other Receivables |
1,269,840.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
280,411,983.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,932,356.78 |
| Total Current Assets |
1,251,327,213.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
198,169,449.57 |
| Investment Properties |
-- |
| Fixed Assetes |
764,453,565.40 |
| Under-construction Projects |
53,438,096.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,662,469.07 |
| R&D expenses |
22,160,473.01 |
| Goodwill |
31,821,553.97 |
| Long-Term Deferred and Prepaid Expenses |
16,325,716.88 |
| Deferred Income Tax Assets |
36,625,544.33 |
| Other Non-Current Assets |
5,590,064.53 |
| Sub-Total of Non-Current Assets |
1,626,387,605.69 |
| Total Assets |
2,877,714,818.93 |
| Short-Term Loans |
103,042,840.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,818,838.23 |
| Accounts Payable |
73,886,157.09 |
| Accounts Received In Advance |
2,900,000.00 |
| Employee Compensation Payable |
8,920,606.89 |
| Taxes Payable |
5,740,376.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,386,801.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,636,912.53 |
| Other Current Liabilities |
279,208.77 |
| Sub-Total of Current Liabilities |
289,595,984.04 |
| Long-term Loans |
144,431,750.07 |
| Bonds Payable |
435,137,816.06 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
55,394,209.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
654,149,440.95 |
| Total Liabilities |
943,745,424.99 |
| Paid-In Capital(Or Share Stock) |
491,934,152.00 |
| Capital Surplus |
135,214,552.22 |
| Surplus Reserve |
147,763,425.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
883,729,954.84 |
| Minority Stockholder's Interest |
144,775,449.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,789,193,944.87 |
| Owner's Equity（Stockholder's Equity） |
1,933,969,393.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,877,714,818.93 |
